CEDARHURST, NY, Nov. 09, 2022 (GLOBE NEWSWIRE) — The securities litigation practice of Kuznicki Law PLLC is issuing this warning to shareholders of Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they purchased the company’s securities between May and otherwise acquired June 28, 2021 and June 1, 2022 inclusive (the “Collection Period”) and/or the Company’s American Depositary Shares (“ADSs”) pursuant to the Company’s initial public offering in May 2021 (the “IPO”) or otherwise have acquired. Shareholders have up to November 28, 2022 filing the lead plaintiff’s motions in the securities class action.

Shareholders are encouraged to contact us at https://kclasslaw.com/cases/securities/nasdaqgs-cnta/by calling toll-free at 1-833-835-1495 or by email ([email protected]).

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The Company seeks redress on behalf of investors who have suffered losses where false and/or misleading information or the omission of material information by a company has artificially inflated the company’s shares. attorney advertising. Previous results do not guarantee similar results.

CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: [email protected]
Phone: (347) 696-1134
Cellphone: (347) 690-0692
Fax: (347) 348-0967
https://kclasslaw.com